Overexpression of TIGIT in NK and T Cells Contributes to Tumor Immune Escape in Myelodysplastic Syndromes

OBJECTIVE: Targeting immune checkpoints, such as PD-1, represents a promising approach for cancer immunotherapy, achieving long-term disease remission rates in numerous types of cancer. T cell immunoglobulin and ITIM domain (TIGIT) is a checkpoint receptor associated with the antitumor roles of NK a...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Fanqiao, Li, Lijuan, Lu, Fengzhu, Yue, Jing, Liu, Zhaoyun, Zhang, Wei, Fu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438899/
https://www.ncbi.nlm.nih.gov/pubmed/32903786
http://dx.doi.org/10.3389/fonc.2020.01595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438899/
https://www.ncbi.nlm.nih.gov/pubmed/32903786
http://dx.doi.org/10.3389/fonc.2020.01595

Ejemplares similares